Lv72
4390 积分 2021-08-31 加入
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity
6天前
已完结
Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies
6天前
已完结
Membranous nephropathy
7天前
已完结
Current trial landscape of IgA nephropathy therapy
10天前
已完结
Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design
1个月前
已关闭
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
1个月前
已完结
Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study
1个月前
已完结
The NLRP3 inflammasome in fibrosis and aging: The known unknowns
1个月前
已完结
Real-World Efficacy and Safety of Inclisiran
1个月前
已完结
皖公网安备34019202002308
